Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec;10(12):1314-24.
doi: 10.1593/neo.81372.

Neoplasia: the second decade

Alnawaz Rehemtulla  1
Affiliations
Free PMC article

Neoplasia: the second decade

Alnawaz Rehemtulla. Neoplasia. 2008 Dec.
Free PMC article

Abstract

This issue marks the end of the 10-year anniversary of Neoplasia where we have seen exciting growth in both number of submitted and published articles in Neoplasia. Neoplasia was first published in 1999. During the past 10 years, Neoplasia has dynamically adapted to the needs of the cancer research community as technologies have advanced. Neoplasia is currently providing access to articles through PubMed Central to continue to facilitate rapid broad-based dissemination of published findings to the scientific community through an Open Access model. This has in part helped Neoplasia to achieve an improved impact factor this past year, demonstrating that the manuscripts published by Neoplasia are of great interest to the overall cancer research community. This past year, Neoplasia received a record number of articles for review and has had a 21% increase in the number of published articles.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A plot of the percent increase in the number of articles published in Neoplasia from 2006 to 2008. For each year, the bar graph indicates the percentage increase over the prior year. Note a major jump in the percentage of published articles occurred in 2008, which was 21% more than that in the previous year.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Klein PJ, Schmidt CM, Wiesenauer CA, Choi JN, Gage EA, Yip-Schneider MT, Wiebke EA, Wang Y, Omer C, Sebolt-Leopold JS. The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer. Neoplasia. 2006;8:1–8. - PMC - PubMed
    1. Andriani F, Perego P, Carenini N, Sozzi G, Roz L. Increased sensitivity to cisplatin in non-small lung cancer cell lines after FHIT gene transfer. Neoplasia. 2006;8:9–17. - PMC - PubMed
    1. Kiewlich D, Zhang J, Gross C, Xia W, Larsen B, Cobb RR, Biroc S, Gu J, Sato T, Light DR, et al. Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth. Neoplasia. 2006;8:18–30. - PMC - PubMed
    1. Watson GA, Queiroz de Oliveira PE, Stang MT, Armstrong MJ, Gooding WE, Kuan S, Yim JH, Hughes SJ. Ad-IRF-1 induces apoptosis in esophageal adenocarcinoma. Neoplasia. 2006;8:31–37. - PMC - PubMed
    1. Chekerov R, Klaman I, Zafrakas M, Koensgen D, Mustea A, Petschke B, Lichtenegger W, Sehouli JJ, Dahl E. Altered expression pattern of topoisomerase IIα (TOP2A) in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy. Neoplasia. 2006;8:38–45. - PMC - PubMed

LinkOut - more resources